Donald Hricik is a Nephrology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 230 publications with 10,298 citations (h-index 57); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 29 Dec 2020.
Clinical trials
- Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 1985–2000 per NIH RePORTER. The latest:
- STABLE RENAL TRANSPLANT PTS TREATED FOLLOWING CONVERSION TO NEORAL THERAPY OLN455
Case Western Reserve University
FY2000$19,199M01RR000080 - STABLE RENAL TRANSPLANT PTS TREATED FOLLOWING CONVERSION TO NEORAL THERAPY OLN455
Case Western Reserve University
FY1999M01RR000080 - STABLE RENAL TRANSPLANT PTS TREATED FOLLOWING CONVERSION TO NEORAL THERAPY OLN455
Case Western Reserve University
FY1998M01RR000080
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
Journal of the American Society of Nephrology
2015 - Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study
American Journal of Transplantation
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”